RXD vs. QTJL
RXD (ProShares UltraShort Health Care) and QTJL (Innovator Growth Accelerated Plus ETF - July) are both Leveraged Equities funds. RXD is passively managed, while QTJL is actively managed. Over the past 5 years, RXD returned -7.59%/yr vs 9.06%/yr for QTJL. Their -0.44 correlation means they have often moved in opposite directions in the past. RXD charges 0.95%/yr vs 0.79%/yr for QTJL.
Performance
RXD vs. QTJL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RXD achieves a -10.24% return, which is significantly lower than QTJL's 2.56% return.
RXD
- 1D
- 0.47%
- 1M
- 0.46%
- 6M
- -10.79%
- YTD
- -10.24%
- 1Y
- -35.49%
- 3Y*
- -10.24%
- 5Y*
- -7.59%
- 10Y*
- -19.63%
- ALL TIME*
- -22.75%
QTJL
- 1D
- 0.93%
- 1M
- -1.97%
- 6M
- 1.77%
- YTD
- 2.56%
- 1Y
- 11.97%
- 3Y*
- 15.99%
- 5Y*
- 9.06%
- 10Y*
- —
- ALL TIME*
- 9.33%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $200.88K | $354.66K | $247.25K | |
| $208.34K | $158.30K | $97.64K |
RXD vs. QTJL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
RXD ProShares UltraShort Health Care | -10.24% | -21.66% | 4.83% | 3.25% | 1.20% | -20.03% |
QTJL Innovator Growth Accelerated Plus ETF - July | 2.56% | 21.07% | 16.50% | 42.39% | -30.16% | 9.36% |
Correlation
The correlation between RXD and QTJL is -0.09, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.09 |
Correlation (3Y) Balances recent behavior with more history. | -0.28 |
Correlation (5Y) Shows whether the relationship held over a longer period. | -0.44 |
Correlation (All Time) Calculated using the full available price history since Jul 1, 2021 | -0.44 |
Over the past year, the inverse relationship between RXD and QTJL has weakened: their correlation has moved from -0.44 to -0.09, meaning they move in opposite directions less often than they have historically.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RXD vs. QTJL — Risk / Return Rank
RXD
QTJL
RXD vs. QTJL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Health Care (RXD) and Innovator Growth Accelerated Plus ETF - July (QTJL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RXD | QTJL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.06 | ||
| Sortino ratioReturn per unit of downside risk | -2.93 | ||
| Omega ratioGain probability vs. loss probability | 0.81 | 1.18 | -0.37 |
| Calmar ratioReturn relative to maximum drawdown | -0.89 | 1.23 | -2.12 |
| Martin ratioReturn relative to average drawdown | -1.40 | 6.04 | -7.44 |
Loading charts...
Drawdowns
RXD vs. QTJL - Drawdown Comparison
The maximum RXD drawdown since its inception was -99.68%, which is greater than QTJL's maximum drawdown of -33.40%. Use the drawdown chart below to compare losses from any high point for RXD and QTJL.
Loading charts...
Drawdown Indicators
| RXD | QTJL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.68% | -33.40% | -66.28% |
Max Drawdown (1Y)Largest decline over 1 year | -40.79% | -8.48% | -32.31% |
Max Drawdown (3Y)Largest decline over 3 years | -42.58% | -22.43% | -20.15% |
Max Drawdown (5Y)Largest decline over 5 years | -46.11% | -33.40% | -12.71% |
Max Drawdown (10Y)Largest decline over 10 years | -91.52% | — | — |
Current DrawdownCurrent decline from peak | -99.67% | -4.62% | -95.05% |
Average DrawdownAverage peak-to-trough decline | -82.00% | -7.74% | -74.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.78% | 1.73% | +24.05% |
Volatility
RXD vs. QTJL - Volatility Comparison
ProShares UltraShort Health Care (RXD) has a higher volatility of 11.80% compared to Innovator Growth Accelerated Plus ETF - July (QTJL) at 6.45%. This indicates that RXD's price experiences larger fluctuations and is considered to be riskier than QTJL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RXD | QTJL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.80% | 6.45% | +5.35% |
Volatility (6M)Calculated over the trailing 6-month period | 24.09% | 9.63% | +14.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.60% | 11.72% | +19.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 30.35% | 20.43% | +9.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.15% | 20.30% | +12.85% |
RXD vs. QTJL - Expense Ratio Comparison
RXD has a 0.95% expense ratio, which is higher than QTJL's 0.79% expense ratio.
Dividends
RXD vs. QTJL - Dividend Comparison
RXD's dividend yield for the trailing twelve months is around 3.31%, while QTJL has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
QTJL Innovator Growth Accelerated Plus ETF - July | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RXD ProShares UltraShort Health Care | 3.31% | 3.29% | 4.36% | 3.17% | 0.67% | 0.00% | 0.17% | 1.73% | 0.22% |
Frequently Asked Questions
RXD and QTJL have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RXD has higher volatility (11.80%) compared to QTJL (6.45%). In terms of maximum drawdown, RXD dropped -99.68% vs QTJL's -33.40%.
On 5-year performance, QTJL leads with 9.06% vs -7.59% for RXD. On fees, QTJL is cheaper at 0.79% per year. On volatility, QTJL has been the lower-risk option at 6.45%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, QTJL has performed better with a 9.06% return vs -7.59%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
QTJL is cheaper with a 0.79% expense ratio, compared with 0.95% for RXD.
RXD has the higher dividend yield at 3.31%, compared with 0.00% for QTJL.
They also come from different issuers: ProShares and Innovator. Their fees differ too: 0.95% for RXD and 0.79% for QTJL.
QTJL currently has the higher Sharpe Ratio (0.89 vs -1.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RXD and QTJL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer